title: Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction.
abstract: To gain a better understanding of the impact of chronic obstructive pulmonary disease (COPD) on long-term mortality in patients with myocardial infarction (MI) and identify areas where the clinical care for these patients may be improved.
  
  
  
  Patients hospitalised for MI between 2005 and 2010 were identified from the nationwide Swedish SWEDEHEART registry. Patients with MI and a prior COPD hospital discharge diagnosis were compared to patients with MI without a prior COPD hospital discharge diagnosis for the primary endpoint of all-cause mortality at 1 year after MI. Secondary endpoints included rates of reinfarction, new-onset stroke, new-onset bleeding and new-onset heart failure at 1 year.
  
  
  
  A total of 81 191 MI patients were included, of which 4867 (6%) had a COPD hospital discharge diagnosis at baseline. Patients with COPD showed a significantly higher unadjusted 1-year mortality (24.6 vs 13.8%) as well as a higher rate of reinfarction, new-onset bleeding and new-onset heart failure post-MI. After adjustment for potential confounders, including comorbidities and treatment, the patients with COPD still showed a significantly higher 1-year mortality (HR 1.14, 95% CI 1.07 to 1.21) as well as a higher rate of new-onset heart failure (HR 1.35, 95% CI 1.24 to 1.47), whereas no significant association between COPD and myocardial reinfarction or new-onset bleeding remained.
  
  
  
  In this nationwide contemporary study, patients with COPD frequently had an atypical presentation, less often underwent revascularisation and less often received guideline-recommended secondary preventive medications of established benefit. Prior COPD was associated with a higher 1-year mortality and a higher risk of subsequent new-onset heart failure after MI. The association seems to be mainly explained by differences in background characteristics, comorbidities and treatment, although a minor part might be explained by COPD in itself. Improved in-hospital MI treatment and post-MI secondary prevention according to the guidelines may lower the mortality in this high-risk population.
authors.affiliation: Department of Cardiology , Lund University , Lund , Sweden.
authors.forename: Pontus
authors.identifier: 0000-0002-2759-1379
authors.initials: P
authors.lastname: Andell
authors.affiliation: Department of Cardiology , Lund University , Lund , Sweden.
authors.forename: Sasha
authors.initials: S
authors.lastname: Koul
authors.affiliation: Department of Cardiology , Lund University , Lund , Sweden.
authors.forename: Andreas
authors.initials: A
authors.lastname: Martinsson
authors.affiliation: Department of Medical Sciences and Cardiology , Uppsala Clinical Research Center , Uppsala University , Uppsala , Sweden.
authors.forename: Johan
authors.initials: J
authors.lastname: Sundström
authors.affiliation: Department of Medicine , Karolinska Institute , Stockholm , Sweden.
authors.forename: Tomas
authors.initials: T
authors.lastname: Jernberg
authors.affiliation: Department of Cardiology , Lund University , Lund , Sweden.
authors.forename: J Gustav
authors.initials: JG
authors.lastname: Smith
authors.affiliation: Department of Medical Sciences and Cardiology , Uppsala Clinical Research Center , Uppsala University , Uppsala , Sweden.
authors.forename: Stefan
authors.initials: S
authors.lastname: James
authors.affiliation: Department of Medical Sciences and Cardiology , Uppsala Clinical Research Center , Uppsala University , Uppsala , Sweden.
authors.forename: Bertil
authors.initials: B
authors.lastname: Lindahl
authors.affiliation: Department of Cardiology , Lund University , Lund , Sweden.
authors.forename: David
authors.initials: D
authors.lastname: Erlinge
keywords: Coronary Artery Disease; Heart Failure